Medochemie Ltd is an International Pharmaceutical Company headquartered in Cyprus. Medochemie manufactures a wide range of products divided into more than 10 therapeutic categories, owns 3800 marketing authorizations and operates in more than 107 countries around the world. Our thirteen separate manufacturing sites are designed to fully comply with European and WHO current Good Manufacturing Practice (cGMP).

We invite applications from highly qualified and motivated professionals for the position of R&D Associate based in Limassol, Cyprus.  

Duties:

• Be responsible for the raw materials sourcing for under development products, by contacting with a variety of external stakeholders.
• Conduct a preliminary and limited quality evaluation of the raw material used for R&D purposes in accordance with the current guidelines in force.
• Apply basic regulatory knowledge under which the medical products are governed.
• Compile consolidated summaries and provide required reports throughout the development of each products in support to the R&D team.
• Support other departments related to the R&D functions and operations when this is required.

Qualifications:

• University degree in Chemistry, Pharmacy or other relevant science degree. A postgraduate degree will be considered as an asset.
• Experience in the pharmaceutical industry it will be considered an advantage. 
• Ability to work collaboratively in a team, and prioritize work in a dynamic and fast moving environment. 
• Very good interpersonal skills, analytical thinking and result orientation.
• Strong computer literacy
• Fluency in English language

We are offering an attractive remuneration package and challenging opportunity for professional development.

If you wish to work in a pleasant, modern, professional environment with excellent career opportunities, please apply online through our web site: https://www.medochemie.com/Careers.aspx

Applicants should note that based on the General Data Protection Regulation (GDPR), all applications/CV’s kept in our database have been deleted.

All applications will be treated in strict confidence.